Chen Yu

2.6k total citations
105 papers, 2.0k citations indexed

About

Chen Yu is a scholar working on Molecular Biology, Analytical Chemistry and Pharmacology. According to data from OpenAlex, Chen Yu has authored 105 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 18 papers in Analytical Chemistry and 16 papers in Pharmacology. Recurrent topics in Chen Yu's work include Analytical Methods in Pharmaceuticals (15 papers), Traditional Chinese Medicine Analysis (8 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Chen Yu is often cited by papers focused on Analytical Methods in Pharmaceuticals (15 papers), Traditional Chinese Medicine Analysis (8 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Chen Yu collaborates with scholars based in China, United States and United Kingdom. Chen Yu's co-authors include Gangyi Liu, Jingying Jia, Shuijun Li, Yang Wang, Xiaochuan Li, Qinghua Xiao, L. Xia, Kaiyu Zhang, Xin Li and Lixin Lou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Chen Yu

103 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen Yu China 26 629 361 263 261 246 105 2.0k
Isadore Kanfer South Africa 28 379 0.6× 297 0.8× 476 1.8× 184 0.7× 238 1.0× 126 2.4k
Christoph Seger Austria 30 1.2k 1.9× 243 0.7× 503 1.9× 302 1.2× 148 0.6× 115 3.1k
Georgia Valsami Greece 27 596 0.9× 224 0.6× 272 1.0× 106 0.4× 96 0.4× 120 2.2k
Jingying Jia China 20 331 0.5× 235 0.7× 164 0.6× 149 0.6× 154 0.6× 86 1.2k
Surendra K. Bansal United States 19 750 1.2× 223 0.6× 302 1.1× 286 1.1× 50 0.2× 45 2.1k
Tejal Gandhi India 22 370 0.6× 225 0.6× 164 0.6× 135 0.5× 151 0.6× 111 1.6k
Fahad I. Al‐Jenoobi Saudi Arabia 29 720 1.1× 99 0.3× 190 0.7× 248 1.0× 356 1.4× 116 2.7k
Dan Yan China 25 1.2k 2.0× 129 0.4× 414 1.6× 160 0.6× 308 1.3× 119 2.6k
José Pedrazzoli Brazil 27 297 0.5× 392 1.1× 180 0.7× 80 0.3× 130 0.5× 69 2.0k
Abdullah M. Al‐Mohizea Saudi Arabia 25 486 0.8× 92 0.3× 165 0.6× 200 0.8× 288 1.2× 88 2.2k

Countries citing papers authored by Chen Yu

Since Specialization
Citations

This map shows the geographic impact of Chen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Yu more than expected).

Fields of papers citing papers by Chen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Yu. The network helps show where Chen Yu may publish in the future.

Co-authorship network of co-authors of Chen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chen Yu. A scholar is included among the top collaborators of Chen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Yu. Chen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yijun, Qian Chen, Yun Liu, et al.. (2025). A first-in-human phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel anti-influenza agent suraxavir marboxil in healthy Chinese subjects. Antimicrobial Agents and Chemotherapy. 69(11). e0068525–e0068525. 1 indexed citations
2.
3.
Yu, Chen, et al.. (2023). Value of plasma AGEs and sRAGE expression in predicting the occurrence of ARDS in elderly COPD patients. Cellular and Molecular Biology. 69(3). 135–138. 1 indexed citations
4.
Zhu, Huijuan, Rong Song, Mengqi Zhang, et al.. (2023). Effect of a high‐fat and high‐calorie food on the pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy subjects. Pharmacology Research & Perspectives. 11(3). e01102–e01102. 2 indexed citations
5.
Cheng, Jie, Yuzhou Gui, Wei Wang, et al.. (2023). A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects. Clinical and Translational Science. 16(9). 1704–1712. 2 indexed citations
6.
Chen, Qian, Qingqing Wu, Rong Song, et al.. (2023). A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects. Frontiers in Pharmacology. 14. 1296672–1296672. 3 indexed citations
7.
Wu, Hao, et al.. (2023). Gastroprotective action of the extract of Corydalis yanhusuo in Helicobacter pylori infection and its bioactive component, dehydrocorydaline. Journal of Ethnopharmacology. 307. 116173–116173. 16 indexed citations
8.
Chen, Qian, Rong Song, Tingting Li, et al.. (2021). A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects. Drug Design Development and Therapy. Volume 15. 2947–2959. 3 indexed citations
9.
Wu, Xue, Qian Chen, Tingting Li, et al.. (2020). Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects. Clinical Therapeutics. 42(9). 1778–1786. 5 indexed citations
10.
Fan, Songhua, Ke Li, Yang Sai, et al.. (2019). Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects. Clinical Therapeutics. 41(8). 1537–1544. 2 indexed citations
11.
Li, Shuang & Chen Yu. (2017). Coping with shortage of plasma - The new therapeutic pattern of non-bioartificial liver. SHILAP Revista de lepidopterología. 1 indexed citations
12.
13.
Qu, Yi, Jing Yan, Gangyi Liu, et al.. (2016). Population pharmacokinetic modeling and simulation of huperzine A in elderly Chinese subjects. Acta Pharmacologica Sinica. 37(7). 994–1001. 6 indexed citations
14.
Liu, Yanmei, Yun Liu, Haichen Zhang, et al.. (2012). Pharmacokinetic Properties and Bioequivalence of Two Sulfadoxine/Pyrimethamine Fixed-Dose Combination Tablets: A Parallel-Design Study in Healthy Chinese Male Volunteers. Clinical Therapeutics. 34(11). 2212–2220. 10 indexed citations
15.
16.
Mengqi, Zhang, Shuijun Li, Gangyi Liu, et al.. (2010). Determination of melamine and cyanuric acid in human urine by a liquid chromatography tandem mass spectrometry. Journal of Chromatography B. 878(9-10). 758–762. 48 indexed citations
17.
Lü, Chuan, Gangyi Liu, Jingying Jia, et al.. (2010). Liquid chromatography tandem mass spectrometry method for determination of N‐acetylcysteine in human plasma using an isotope‐labeled internal standard. Biomedical Chromatography. 25(4). 427–431. 19 indexed citations
18.
Jia, Jingying, Youli Lu, Xiaochuan Li, et al.. (2010). Pharmacokinetics of depside salts from Salvia miltiorrhiza in healthy Chinese volunteers: A randomized, open-label, single-dose study. Current Therapeutic Research. 71(4). 260–271. 20 indexed citations
19.
Li, Shuijun, et al.. (2006). Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography—tandem mass spectrometry. Journal of Chromatography B. 847(2). 174–181. 73 indexed citations
20.
Li, Xinhai, Chen Yu, Yongbing Cai, et al.. (2005). Simultaneous determination of six phenolic constituents of danshen in human serum using liquid chromatography/tandem mass spectrometry. Journal of Chromatography B. 820(1). 41–47. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isadore Kanfer Breakdown of academic impact, for papers by Christoph Seger Breakdown of academic impact, for papers by Georgia Valsami Breakdown of academic impact, for papers by Jingying Jia Breakdown of academic impact, for papers by Surendra K. Bansal Breakdown of academic impact, for papers by Tejal Gandhi Breakdown of academic impact, for papers by Fahad I. Al‐Jenoobi Breakdown of academic impact, for papers by Dan Yan Breakdown of academic impact, for papers by José Pedrazzoli Breakdown of academic impact, for papers by Abdullah M. Al‐Mohizea
Rankless by CCL
2026